Navigation Links
PRA International Experts to Speak at Drug Safety Conference
Date:4/12/2011

RALEIGH, N.C., April 12, 2011 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that two experts from our Safety and Risk Management (SRM) group will speak at the World Drug Safety Congress being held in Boston, MA from 12-15 April 2011. PRA will also host an exhibit at booth #2.

Dr. Sabine Richter, PRA's Vice President of SRM, will chair the first breakout stream, "Operational Safety," on 13 April at 1:50 PM EDT.  Dr. Richter will provide opening remarks and moderate the session, which will address global safety regulatory intelligence, adverse event reporting and risks associated with missing data.

At 2:00 PM EDT, Dr. Kathleen Boyden, PRA's Director of Drug Safety Centers Americas, will deliver a presentation titled, "Adverse Event Monitoring and Global Safety Regulatory Intelligence."  Dr. Boyden will discuss strategies for maintaining global compliance, focusing specifically on relevant cultural, protocol and technological considerations associated with gathering and reporting adverse events.  

Dr. Richter has over 20 years of research experience in the pharmaceutical and CRO industries as well as in academia. Since joining PRA's SRM team in 2004, she has delivered numerous projects for a variety of clients and led large, long-term safety programs involving as many as 50 countries on five continents. As the head of PRA's SRM group, Dr. Richter has developed robust procedures and quality control measures to ensure consistent high performance and regulatory compliance.

Dr. Boyden has nearly 15 years of clinical research experience in academia and the CRO industry.  She joined PRA in 2007 as manager of Clinical Operations responsible for study start-up and legal services.  In 2003, Dr. Boyden earned a Ph.D. in nursing from the University of Virginia, where she conducted funded research as a National Institutes of Health Predoctoral Research Fellow.

Additional PRA representatives from SRM, Clinical Operations and Business Development will be available at our booth to discuss our successful approach to drug development programs.

PRA's SRM group provides services throughout the entire product life cycle. The team includes over 100 experts available to clients for consultancy as well as routine and specialty pharmacovigilance services. Most of these staff members are healthcare professionals (nurses, pharmacists, physicians) or life scientists.  PRA's drug safety centers are based in our Mannheim, Germany; Swansea, UK; Charlottesville, VA (US); and Sao Paulo, Brazil offices.

About PRA

PRA conducts clinical trials across all therapeutic areas in more than 80 countries and provides services in all phases of clinical development through its 39 global offices.

PRA's therapeutic expertise, global reach and project experience combined with its extensive local knowledge and differentiating philosophy—THE PERSONAL ELEMENT— enable its project teams to deliver consistent and on-time performance. This unique PRA philosophy recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to be innovative and to use their personal commitment to accelerate the development life cycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting
2. Mauna Kea Technologies Announces Highlights of Third International Conference of Cellvizio Users (ICCU)
3. Two New U.S. Patents Issued to Dyadic International
4. Mindray Medical to Exhibit New Products at 65th China International Medical Equipment Fair
5. NuAire to Offer Adaptable Laboratory Centrifuges From Awel International
6. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
7. International Isotopes Inc. Announces 2010 Year End Financial Results
8. Ellman International Announces New US Sales Executive
9. SRI International Drug Candidate Shows Promise for Treating and Preventing Prostate Cancer
10. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
11. PRA International Experts to Chair BioPharma Asia Panels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... , June 23, 2016  The National ... has joined the health policy research organization as ... Romano , MD, senior vice president and chief ... company,s representative on the NPC Board of Directors. ... pleased that Mallinckrodt has joined us in support ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):